Outsourcing Intelligence for CRO Teams
Start each day with curated headlines on clinical outsourcing, vendor moves, and regulatory shifts — then read weekly deep dives that connect the news to program risk, capacity, and partner selection.
Feed: /api/seo/feed · Markdown mirrors: /posts/<slug>.md
- Deep diveFDA inspection clinical research organization compliance outsourcing
Sponsors can no longer treat CRO partnerships as outsourced accountability—the FDA now audits vendor ecosystems directly and requires documented, active oversight of contracted research functions. Procurement teams must independently verify CRO capability and maintain audit trails proving sponsor control, not just rely on vendor certifica
- Daily newsCRO Daily News — September 4, 2026
- Fortrea Acquires Worldwide Clinical Trials' Early Phase Division for $45M, Adds 200-Bed CPU and GLP Lab
- Daily newsCRO Daily News — September 2, 2026
- FDA Reinforces GCP Compliance Mandate for Foreign Clinical Trial Sites
- Deep diveDecentralized clinical trial contract research organization capacity
Decentralized clinical trials have moved from niche to mainstream, with pharma companies now demanding distributed, patient-centric models as standard—forcing CROs without integrated digital infrastructure to lose ground to vendors offering unified ecosystems that compress timelines and reduce operational friction.
- Daily newsCRO Daily News — August 25, 2026
- PrimeVigilance Expands MI and PV Technology Stack with Zoom, Klearcom Integration
- Emmes Group Appoints Rama Kondru as CEO
- Deep diveContract research organization clinical trial site recruitment crisis
Clinical trial recruitment is fragmenting across competing technology models while the real bottleneck—workforce capacity and site coordination—remains unsolved, forcing sponsors to demand CROs prove indication-specific site strength rather than betting on technology alone.
- Daily newsCRO Daily News — August 24, 2026
- Novotech Opens Tokyo Office to Expand Japan Clinical Trial Operations
- Novotech Opens Tokyo Office to Expand Clinical Services for Japanese Biotech Sponsors
- Emmes Group Appoints Rama Kondru as CEO; Prioritizes AI and Clinical Technology Integration
- Daily newsCRO Daily News — August 20, 2026
- Revelation Biosciences Taps Avance Clinical for Phase 2/3 TITAN Study in Acute Kidney Injury
- Daily newsCRO Daily News — August 19, 2026
- Syneos Health Embeds Causaly Agentic AI Into Scientific Workflows
- Daily newsCRO Daily News — August 18, 2026
- PrimeVigilance Joins Pistoia Alliance to Advance Pharmacovigilance Standards and AI Safety
- Clinilabs Appoints IQVIA Veteran Laura Shannon as CEO; Founder Transitions to Executive Chair
- BioCytics and LIDE Biotech Partner on PDX Screening for Immuno-Oncology Cell Therapy
- Curavit Acquires Lindus Health CRO Assets to Expand European Clinical Trial Footprint
- Deep diveAI clinical trial operations CRO adoption
CROs are rapidly adopting AI to handle the data volume and regulatory complexity of modern trials, with 82% of users having less than 18 months of implementation experience—making AI capability and regulatory readiness now baseline vendor selection criteria rather than competitive advantages.
- Daily newsCRO Daily News — August 17, 2026
- Clinilabs Appoints IQVIA Veteran Laura Shannon as CEO to Drive CNS CRO Growth
- BioCytics and LIDE Biotech Partner on PDX Screening for Immuno-Oncology Cell Therapy
- Deep diveFDA GCP Inspections Drive CRO Selection and Qualification
FDA's intensified GCP inspection regime is forcing sponsors to prioritize regulatory readiness over cost in CRO selection, with vertically integrated vendors gaining advantage by simplifying audit trails and consolidating compliance risk under single oversight. This shift reflects a fundamental reorg of clinical development procurement fr
- Daily newsCRO Daily News — August 10, 2026
- FDA Announces Expedited IND Pilot Program Webinar for Qualified Research Institutions
- Daily newsCRO Daily News — August 6, 2026
- Cryoport Q2 2026: 8% Revenue Growth, 779 Clinical Trials Supported
- Daily newsCRO Daily News — August 4, 2026
- Niagen Bioscience Engages Evotec for IND-Enabling Studies on NB4168 Ataxia Telangiectasia Candidate
- Deep diveCRO Consolidation Drives Clinical Services M&A: Buyer Implications
CRO consolidation driven by pharma demand for integrated services is reshaping clinical trial outsourcing, with mega-mergers among both sponsors and vendors forcing buyers to consolidate vendor rosters and demand deeper strategic partnerships from fewer, more capable partners. For procurement teams, this means navigating tighter vendor co
- Daily newsCRO Daily News — July 30, 2026
- Quartesian Founders Launch Acrosian, AI-Native Biometrics CRO
- Daily newsCRO Daily News — July 29, 2026
- Why Clinical Trials Are Leaving the US: Expert Q&A on FDA's Project TrialBlazer Limits
- Daily newsCRO Daily News — July 28, 2026
- Humanized Mouse Models and BBB-Crossing Design Critical to CNS Drug De-Risking
- FDA Expedited IND Pilot Program and Phase 1 Modernization Initiative
- Deep diveBIOSECURE Act drives CRO and CDMO reshoring for biopharma
BIOSECURE Act mandates ongoing vendor compliance and geographic de-risking for biopharma, shifting CRO selection from cost-driven to security-driven and accelerating consolidation among smaller biotech unable to absorb compliance costs and delays.
- Daily newsCRO Daily News — July 27, 2026
- KGK Science Secures Growth Investment to Expand Clinical Trial and Regulatory Capacity
- FDA Expedited IND Pilot Program Webinar: QRI Network for First-in-Human Trials
- Daily newsCRO Daily News — July 24, 2026
- PrimeVigilance Earns Veeva Services Partner Certification for Pharmacovigilance Case Processing
- Daily newsCRO Daily News — July 22, 2026
- SK pharmteco Advances AAV Gene Therapy to Phase III with 20 Clinical Batches for Genethon DMD Program
- Deep diveClinical Trial Recruitment Bottlenecks Drive Outsourcing Demand for CROs
Enrollment failures delay 80% of trials at crushing costs, forcing sponsors to treat patient recruitment as a strategic outsourcing priority rather than a site-level problem—making specialized CROs essential partners in de-risking timelines and protecting market exclusivity.
- Daily newsCRO Daily News — July 17, 2026
- Crown Bioscience Joins C-Path NAMs Coalition to Validate Human-Relevant Preclinical Models
- Daily newsCRO Daily News — July 15, 2026
- CovarsaDx Exhibits IVD Clinical Research Capabilities at ADLM 2026
- Deep diveAI adoption drives 65% of outsourced pharma R&D spending in 2026
AI-driven clinical trial optimization is reshaping pharma outsourcing economics, with CROs that embed AI for patient matching and predictive safety monitoring capturing disproportionate contract value as regulatory clarity enables enterprise-scale deployment. Procurement leaders must now evaluate vendors on AI integration depth and regula
- Daily newsCRO Daily News — June 28, 2026
- Advanced Clinical Partners with Cognitive Clinical Trials to Enhance Alzheimer's Patient Recruitment
- Daily newsCRO Daily News — June 22, 2026
- FDA Streamlines Early-Stage IND Submissions and Late-Stage Trial Evidence Standards
- Daily newsCRO Daily News — June 11, 2026
- HkeyBio Launches NHP Fast-PoC Program for Low-Cost Cynomolgus PK/PD Validation
- Daily newsCRO Daily News — June 6, 2026
- SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
- Innovent declares Phase 3 success for ADC that attracted huge Takeda deal
- Zifo Transforms EHS Policy Management with New AI-Enabled Services Accelerator
- VetrixBio Announces Positive Clinical Data for VTX-304, a First-in-Class Bispecific Antibody for Canine Osteoarthritis
- Grifols Supports AlphaDetect to Accelerate Detection of Alpha-1